Combined concomitant boost radiotherapy and chemotherapy in stage III–IV head and neck carcinomas: A comparison of toxicity and treatment results with those observed after radiotherapy alone-Reference-Cited by-同舟云学术

Combined concomitant boost radiotherapy and chemotherapy in stage III–IV head and neck carcinomas: A comparison of toxicity and treatment results with those observed after radiotherapy alone

Published:1997-07 Issue:7 Volume:8 Page:681-684
ISSN:0923-7534
Container-title:Annals of Oncology
language:en
Short-container-title:Annals of Oncology

Author:

Allal A.S.,Bieri S.,Miralbell R.,Dulguerov P.,Bardina A.,Lehmann W.,Kurtz J.M.

Publisher

Elsevier BV

Subject

Oncology,Hematology

Link

http://academic.oup.com/annonc/article-pdf/8/7/681/19481078/8-7-681.pdf

Reference29 articles.

1. Hyperfractionation versus conventional fractionation in oropharyngeal carcinoma: Final analysis of a randomized trial of the EORTC cooperative group of radiotherapy;Horiot;Radiother Oncol,1992

2. Single fraction per day versus two fractions per day versus radiochemotherapy in the treatment of head and neck cancer;Sanchiz;Int J Radiat Oncol Biol Phys,1990

3. Treatment of advanced squamous-cell carcinoma of the head and neck with alternating chemotherapy and radiotherapy;Merlano;N Engl J Med,1992

4. Twice-a-day radiation therapy for cancer of the head and neck;Wang;Cancer,1985

5. Early results of the EORTC randomized clinical trial on multiple fractions per day (MFD) and misonidazole in advanced head and neck cancer;Van den Bogaert;Int J Radiat Oncol Biol Phys,1986

Cited by 13 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Tumor volume as prognostic factor in chemoradiation for advanced head and neck cancer;Head & Neck;2010-07-13

2. Relationship between clinical factors and the incidence of toxicity after intra-arterial chemoradiation for head and neck cancer;Radiotherapy and Oncology;2006-11

3. Phase I Trial of Concomitant Hyperfractionated Radiotherapy with Docetaxel and Cisplatin for Locally Advanced Head and Neck Cancer;The Cancer Journal;2006-01

4. Prediction of outcome in head-and-neck cancer patients using the standardized uptake value of 2-[18f]fluoro-2-deoxy-d-glucose;International Journal of Radiation Oncology*Biology*Physics;2004-08

5. Can concomitant-boost accelerated radiotherapy be adopted as routine treatment for head-and-neck cancers? a 10-year single-institution experience;International Journal of Radiation Oncology*Biology*Physics;2004-04